Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
about
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewA microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphomaUnravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clusteringDiffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma.Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.Array-comparative genomic hybridization profiling of immunohistochemical subgroups of diffuse large B-cell lymphoma shows distinct genomic alterationsGene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathwaysClonal heterogeneity of lymphoid malignancies correlates with poor prognosis.Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma.Amplification of 2p as a genomic marker for transformation in lymphoma.Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas.The c-Rel Transcription Factor in Development and Disease.Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines.STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomasATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma.The molecular biology of diffuse large B-cell lymphoma.Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large B-cell lymphoma cells and their association with clinical featuresDNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.Genetic differences between Asian and Caucasian chronic lymphocytic leukemia.Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q: A Case ReportHigh resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the diseaseThe molecular background of aggressive B cell lymphomas as a basis for targeted therapy.Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.The role of high-throughput technologies in clinical cancer genomics.Recent advances in de novo CD5+ diffuse large B cell lymphoma.XV. Malignant lymphoma as a consequence of clonal evolution.Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.
P2860
Q24652565-51FC2ADB-3A94-44F8-A4CD-49ABCEE7A283Q27304386-08EA44D5-8443-4D40-B6F8-1D084B733078Q30485971-8452B56F-0CD9-4F10-941A-8BC384B0BFB4Q33299950-72DE2FED-C77E-4749-90CE-98D5B32770BEQ33688416-EDE742E7-83B8-472A-B626-00CDD22216FBQ33870491-83FC349A-A821-4038-9219-7B965895CC84Q34983966-E0A70146-73F3-468A-9D0D-CD80B6EF0347Q35006744-A1C04A77-56D6-4DBE-83A6-BE843F4E1523Q35051460-58366A29-03EB-4547-8FE1-C63DCCFC9464Q35051575-1B930FDF-3035-4476-B12D-D8424A3A8A86Q35051842-E68BE180-A4A6-40C0-97DF-DB57FC60BBF4Q35067195-8D204E53-E1F8-4BCC-BF92-A972FB513EA2Q35082512-9C4D6139-41F6-42E0-8129-EB5B96F001ECQ35119804-8EF824DD-0944-4CB0-A912-57C9EB341790Q35204449-23AFE2B2-76B2-47C3-B4C4-A760B1F3D1FBQ35396525-E5C8EF0D-D0F2-402E-B0CF-4331912BB8B3Q35440675-693BCC89-5524-4D73-8BDD-A505F5E20F75Q35556506-C979ED0C-AA72-4D57-84B2-BB3100CA7E45Q35790266-C7276B0B-CDC0-43E5-BD2C-C8DAAC39627BQ36262870-766B4ED9-11D9-45F6-83AC-D194D5BE85BCQ36274840-3A8898C5-333B-4109-9F76-713252836512Q36350416-5472C7D6-A281-4CDA-87F5-02152E2739B8Q36612630-D153D9A8-6F47-43EC-A2AB-0A2CE5AE46C2Q36757502-09DC73BB-D4B0-471B-8484-CAF1E1B32190Q36918646-8AFD50D7-1382-49BF-A268-EBD60E506570Q37124632-54E5C894-90D0-4AC3-BA1A-DB1AE86864F4Q37178396-AA5E2450-77F7-4E86-B3A4-C8E76E123B29Q37206989-76710EEE-62A8-40F2-AAC7-A960900D57BDQ37335051-A4286757-F598-436B-AE4C-5E3025C77247Q37365459-0B59FC87-C68F-4B60-AB7D-A2270923BFF7Q37545385-936E69D1-E248-415A-8C7A-1D721D84C306Q37700542-3DAB8E10-E37A-4136-9BD1-17CF6FE7EA08Q37815142-259B0F25-4856-4AC4-81F4-1297586D5051Q37874219-E940E207-B325-4749-98B5-CF9104714589Q38042513-103EC734-3C5B-46AE-B7C0-FB6DDF6A9BF0Q38088010-A59F398A-D4DD-4A94-8487-4EB4C4B2F5C2Q38108555-ECB74D91-D37D-479A-A1F8-658542E76536Q38115235-1B31324C-AE22-47BE-8529-7571CD0E4E56Q38193997-41DD1905-D008-404F-B02F-A407F2CED7FBQ38798801-2D281EE4-363D-44C5-83BB-65181ADF51AF
P2860
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@en
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@nl
type
label
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@en
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@en
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@nl
P2093
P1433
P1476
Comparison of genome profiles ...... diffuse large B-cell lymphoma.
@en
P2093
Hiroyuki Tagawa
Koichi Ohshima
Masao Seto
Masataka Okamoto
Miyuki Suguro
Shigeo Nakamura
Shinobu Tsuzuki
Sivasundaram Karnan
Yasuo Morishima
P304
P356
10.1182/BLOOD-2005-02-0542
P407
P577
2005-05-10T00:00:00Z